Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Tempest Therapeutics, Inc.(TPST) | 0 | 3,507,055 | +3,507,055 | 0 | 2,588 | 4.30% | +2,588 |
| Adverum Biotechnologies, Inc. | 506,821 | 506,821 | 0 | 2,367 | 2,215 | 3.68% | -152 |
| Repare Therapeutics, Inc. | 2,646,657 | 2,646,657 | 0 | 3,467 | 2,609 | 4.33% | -858 |
| Skye Bioscience, Inc.(SKYE) | 2,007,704 | 2,007,704 | 0 | 5,682 | 3,192 | 5.30% | -2,490 |
| CRISPR Therapeutics AG(CRSP) | 498,558 | 498,558 | 0 | 19,623 | 16,966 | 28.18% | -2,657 |
| Tempest Therapeutics, Inc.(TPST) | 3,507,055 | 0 | -3,507,055 | 2,927 | 0 | — | -2,927 |
| Contineum Therapeutics, Inc.(CTNM) | 918,163 | 918,163 | 0 | 13,451 | 6,409 | 10.64% | -7,042 |
| Monte Rosa Therapeutics, Inc.(GLUE) | 5,652,922 | 5,652,922 | 0 | 39,231 | 26,230 | 43.56% | -13,002 |